47 results on '"Derosa G."'
Search Results
2. Long-term predictors of impaired fasting glucose and type 2 diabetes in subjects with family history of type 2 diabetes: A 12-years follow-up of the Brisighella Heart Study historical cohort
3. Thiazolidinediones plus metformin association on body weight in patients with type 2 diabetes
4. Procedures and results of the measurements on large area photomultipliers for the NEMO project
5. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects
6. Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates
7. EFFECTS OF SIBERIAN GINSENG (ELEUTHEROCOCCUS SENTICOSUS MAXIM.) ON ELDERLY QUALITY OF LIFE: A RANDOMIZED CLINICAL TRIAL
8. Effects Of Pcsk-9 Inhibitors On Lipid Profile: An Italian, Real Life, Multicentric Experience
9. Effects of sitagliptin on lipid profile in type 2 diabetic patients after seven years of therapy
10. 828 Antitumor activity of nanovectors encapsulating zoledronic acid (ZOL) in 3D prostate carcinoma spheroids
11. 20 LOSARTAN ALONE OR COMBINED WITH SIMVASTATIN IMPROVED VISCERAL ADIPOSE TISSUE AND INFLAMMATION IN HYPERTENSIVE NORMOCHOLESTEROLEMIC PATIENTS WITH NON-ALCOHOLIC HEPATIC STEATOSIS
12. MS2 EFFECTS OF SIBUTRAMINE PLUS L-CARNITINE COMPARED TO SIBUTRAMINE OR PLACEBO ON INFLAMMATORY PARAMETERS
13. W22 QUALITY OF LIFE OF CHILDREN WITH FAMILIAL HYPERLIPIDEMIAS AFTER QUANTITATIVE OR QUALITATIVE DIETARY RESTRICTION
14. Liposomes containing zoledronic acid: A new opportunity against cancer
15. Abstract: P1266 EFFICACY OF SIMVASTATIN AND FENOFIBRATE ASSOCIATION IN HYPERCHOLESTEROLEMIC, TYPE 2 DIABETIC PATIENTS COMPARED TO MONOTHERAPY
16. Abstract: P782 EFFECTS OF ATORVASTATIN-FENOFIBRATE COMBINATION COMPARED TO ATORVASTATIN MONOTHERAPY ON LIPID PROFILE IN PATIENTS WITH COMBINED DYSLIPIDEMIA
17. Abstract: P783 EFFECT OF MANIDIPINE-ROSUVASTATIN COMBINATION ON FIBRINOLYSIS, INFLAMMATION MARKERS AND INSULIN SENSITIVITY IN HYPERTENSIVE HYPERCHOLESTEROLEMIC PATIENTS
18. [27] RISK PERCEPTION AND QUALITY OF LIFE IN CHILDREN WITH FAMILIAL HYPERLIPIDEMIAS AND THEIR PARENTS BEFORE AND AFTER LIFE-STYLE COUNSELING
19. 35 EVALUATION OF METALLOPROTEINASE 2 AND 9 LEVELS AND THEIR INHIBITORS IN COMBINED DYSLIPIDEMIA DURING OMEGA-3 POLYUNSATURATED FATTY ACIDS THERAPY
20. 36 EVALUATION OF METALLOPROTEINASE 2 AND 9 LEVELS AND THEIR INHIBITORS IN COMBINED DYSLIPIDEMIA
21. 27 METABOLIC EFFECT OF A SEQUENTIAL TRAINING PROGRAM ON HYPERTENSIVE OVERWEIGHT PATIENTS WITH AND WITHOUT METABOLIC SYNDROME
22. 28 PHYSICAL TRAINING MODULATION OF PROTHROMBOTIC AND MICROINFLAMMATORY PARAMETERS IN HYPERTENSIVE OVERWEIGHT PATIENTS
23. 29 EFFECT OF PHYSICAL ACTIVITY ON VASCULAR REMODELLING BIOMARKERS IN HYPERTENSIVE OVERWEIGHT PATIENTS
24. 25 LONG-TERM EFFECTIVENESS AND SAFETY OF A NUTRACEUTICAL BASED APPROACH TO REDUCE CHOLESTEROLEMIA IN STATIN INTOLERANT SUBJECTS WITH AND WITHOUT METABOLIC SYNDROME
25. PO22-698 EFFECT OF TELMISARTAN ON FASTING AND POSTPRANDIAL INFLAMMATION MARKERS IN DIABETIC HYPERTENSIVE PATIENTS
26. PO20-625 EFFICACY OF SOLUBLE FIBER SUPPLEMENTATION IN CVD RISK MANAGEMENT OF PATIENTS AFFECTED BY METABOLIC SYNDROME: A 6-MONTHS, OPEN-LABEL, RCT
27. PO11-311 MMP-2, MMP-9 AND THEIR INHIBITORS AND OTHER PROTHROMBOTIC RISK FACTORS PLASMA LEVEL IN FCH, MS, FCH+MS AND CONTROL SUBJECTS
28. PO9-200 INFLAMMATION MARKERS AND MMPS IN NONDIABETIC AND DIABETIC SUBJECTS DURING OGTT
29. We-P14:482 Efficacy of soluble fiber supplementation in CV disease risk management of patients with metabolic syndrome: A 6-months, randomized clinical trial
30. We-P11:93 Combining natural treatments to reach lipid target in metabolic syndrome patients: A randomized clinical trial
31. We-P11:65 Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin
32. Tu-P7:255 Matrix metalloproteinases and tissue inhibitor metalloproteinases in hypertensive patients
33. Tu-P7:254 Matrix metalloproteinases and tissue inhibitor metalloproteinases in hypertensive patients before and after antihypertensive therapy
34. P124 Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients
35. Hyperinsulinemia and small vessel wall remodeling in obese Zucker rats
36. Comparison between diet, orlistat and cerivastatin in hypercholesterolemic, obese patients, with mild hypertension
37. Comparison between perindopril and candesartan in hypertensive patients with type 2 diabetes: evaluation of lipid profile and Lp (a)
38. Effects of fosinopril on lipid profile and Lp(a) in normotensive patients with type 2 diabetes and microalbuminuria
39. Changes in blood pressure (BP) in experimental glomerulopathy by polysaccharides
40. Role of renal vascular damage (RVD) in patients with systemic lupus erythematosus (SLE)
41. Arterial hyalinosis in kidney vessels. A real index for renal prognosis in diabetic patients?
42. Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects
43. Fractures in Children: General Consideration and Treatment of Open Fractures
44. Chest wall resection and reconstruction for malignant conditions in childhood
45. Metabolic implications of the distribution of the alanine aminotransferase isoenzymes.
46. Smaller, denser LDL particles are not a risk factor for cardiovascular disease in healthy nonagenarian women of the Cremona Population Study
47. G34 - Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjecfs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.